Ledger.Open graph →
SEC Form D · filed January 18, 2017

Osmol Therapeutics, Inc

Offering
$3.0M
Sold
$550K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW HAVEN, CT
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (2)

Brian Dixon · New Haven, CTExec · DirectorBrian Dixon · New Haven, CTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗